NASDAQ:OMPI - Obagi Medical Products Stock Price, Price Target & More

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Obagi Medical Products (NASDAQ:OMPI)

Obagi Medical Products logoObagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Obagi sells its products through a direct sales force in the United States and internationally through distribution partners in over 43 countries across North America, Central America, Europe, the Middle East and Asia. In April 2013, Valeant Pharmaceuticals International Inc acquired the entire share capital of Obagi Medical Products Inc.

Receive OMPI News and Ratings via Email

Sign-up to receive the latest news and ratings for OMPI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Obagi Medical Products (NASDAQ:OMPI) Frequently Asked Questions

What is Obagi Medical Products' stock symbol?

Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI."

Has Obagi Medical Products been receiving favorable news coverage?

Media coverage about OMPI stock has trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Obagi Medical Products earned a daily sentiment score of 0.20 on Accern's scale. They also assigned news articles about the specialty pharmaceutical company an impact score of 47.26 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Obagi Medical Products?

Shares of OMPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Obagi Medical Products?

Obagi Medical Products' mailing address is 50 Technology Drive, IRVINE, CA 92618, United States. The specialty pharmaceutical company can be reached via phone at +1-562-6281007.

MarketBeat Community Rating for Obagi Medical Products (OMPI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  127
MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe OMPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMPI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Obagi Medical Products (NASDAQ:OMPI) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/24/2016 forward)


Obagi Medical Products (NASDAQ:OMPI) Earnings History and Estimates Chart

Earnings by Quarter for Obagi Medical Products (NASDAQ:OMPI)

Obagi Medical Products (NASDAQ OMPI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2013Q4 2012$0.21$0.15$30.06 million$30.30 millionViewListenView Earnings Details
11/1/2012Q312$0.20$0.22$28.87 million$29.10 millionViewN/AView Earnings Details
8/2/2012$0.20$0.22ViewN/AView Earnings Details
5/3/2012$0.21$0.16ViewN/AView Earnings Details
3/8/2012$0.19$0.27ViewN/AView Earnings Details
11/9/2011$0.17$0.24ViewN/AView Earnings Details
8/4/2011$0.16$0.18ViewN/AView Earnings Details
5/5/2011$0.13$0.16ViewN/AView Earnings Details
3/10/2011$0.09$0.14ViewN/AView Earnings Details
11/4/2010Q3 2010$0.10$0.15ViewN/AView Earnings Details
8/5/2010Q2 2010$0.17$0.20ViewN/AView Earnings Details
5/6/2010Q1 2010$0.09$0.09ViewN/AView Earnings Details
3/11/2010Q4 2009$0.17$0.22ViewN/AView Earnings Details
11/5/2009Q3 2009$0.14$0.14ViewN/AView Earnings Details
8/6/2009Q2 2009$0.12$0.15ViewN/AView Earnings Details
5/7/2009Q1 2009$0.08$0.08ViewN/AView Earnings Details
3/5/2009Q4 2008$0.13$0.13ViewN/AView Earnings Details
11/6/2008Q3 2008$0.14$0.13ViewN/AView Earnings Details
8/11/2008Q2 2008$0.19$0.20ViewN/AView Earnings Details
5/5/2008Q1 2008$0.18$0.13ViewN/AView Earnings Details
3/3/2008Q4 2007$0.26$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Obagi Medical Products (NASDAQ:OMPI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Obagi Medical Products (NASDAQ OMPI) Insider Trading and Institutional Ownership History

Insider Trading History for Obagi Medical Products (NASDAQ:OMPI)

Obagi Medical Products (NASDAQ OMPI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Obagi Medical Products (NASDAQ OMPI) News Headlines

No headlines for this company have been tracked by

SEC Filings

Obagi Medical Products (NASDAQ:OMPI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Obagi Medical Products (NASDAQ:OMPI) Income Statement, Balance Sheet and Cash Flow Statement


Obagi Medical Products (NASDAQ OMPI) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.